Johnson & JohnsonvsTELA Bio

JNJ and TELA stock compared: price, dividend, valuation and results, from SEC filings.

TELA

TELA Bio, Inc.

$0.71

Value $41M

-2.54%
TELA's page

Johnson & Johnson (JNJ) has a market value of $654B and TELA Bio (TELA) $41M. Over the last year, with dividends, JNJ moved +37.1% and TELA -34.4%. Dividend yield: JNJ 1.94%, TELA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$654B

    TELA$41M

    JNJ is 16,012 times TELA

  • Revenue, 12 months

    JNJ$99.3B

    TELA$78M

    JNJ is 1,271 times TELA

  • Net income, 12 months

    JNJ$16.1B

    TELA-$42M

  • Operating margin

    JNJ–

    TELA-43.2%

  • ROIC

    JNJ12.4%

    TELA-63.7%

    76.1 points apart

  • P/E

    JNJ40.7

    TELA–

  • Dividend yield

    JNJ1.9%

    TELA0.0%

    1.9 points apart

  • 5-year return

    JNJ+91.6%

    TELA-94.4%

    186.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+91.6%

TELA-94.4%

010020020222023202420252026
Returns by period
PeriodJNJWith dividendsTELAWith dividends
1 year since November 19, 2025+37.1%Price +34.1%-34.4%Price -34.4%
3 years since November 20, 2023+95.7%+25.1% a yearPrice +81.1%-85.5%-47.4% a yearPrice -85.5%
5 years since November 19, 2021+91.6%+13.9% a yearPrice +66.7%-94.4%-43.8% a yearPrice -94.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonTELATELA Bio

Valuation

JNJTELA
Valuation
Price$271.57$0.71
Market value$654B$41M
Enterprise value (EV)$682B$130M
P/E40.7–
P/E, 5-year median21.9–
P/B8.0–
EV/EBIT38.4–
Free cash flow yield3.2%–

Results and growth

JNJTELA
Results and growth
Revenue, 12 months$99.3B$78M
Net income, 12 months$16.1B-$42M
Free cash flow, 12 months$20.6B-$34M
Earnings per share, 12 months$6.59-$0.74
Revenue growth, year on year6.1%15.8%
Revenue growth a year, past+2.7%over 5 years+34.5%over 5 years
EPS growth a year, past+14.9%over 5 years–

Margins and returns on capital

JNJTELA
Margins and returns on capital
Gross margin67.6%67.2%
Operating margin–-43.2%
Net margin16.2%-53.6%
ROIC12.4%-63.7%
ROE19.7%–

Balance sheet

JNJTELA
Balance sheet
Cash$17.2B$23M
Total debt$44.7B$112M
Net debt / EBITDA1.1–
Interest cover18.0×-4.3×

Dividends and buybacks

JNJTELA
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or TELA

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or TELA Bio?

By market value, Johnson & Johnson ($654B) is about 16,012.0 times TELA Bio ($41M), at today's prices.

How did JNJ and TELA stock do over the last 5 years?

Since November 19, 2021, JNJ's price moved +66.7% and TELA's -94.4%. With dividends: JNJ +91.6% (+13.9% a year), TELA -94.4% (-43.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or TELA?

The dividend yield at today's price is 1.94% for Johnson & Johnson and none for TELA Bio. Over the last twelve months they paid $5.28 and – per share.

Which has the higher profit margins, Johnson & Johnson or TELA Bio?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and -53.6% for TELA Bio, and the operating margin – and -43.2%. Revenue was $99.3B and $78M.

Which is the better investment, Johnson & Johnson or TELA Bio?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.